CVS Health Corporation
CVS
$65.75
$0.911.40%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 4.61B | 5.02B | 7.19B | 7.32B | 8.34B |
Total Depreciation and Amortization | 4.60B | 4.58B | 4.55B | 4.50B | 4.37B |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -213.00M | 552.00M | 226.00M | 368.00M | 701.00M |
Change in Net Operating Assets | 109.00M | -5.54B | -3.89B | -1.30B | 15.00M |
Cash from Operations | 9.11B | 4.61B | 8.07B | 10.89B | 13.43B |
Capital Expenditure | -2.78B | -2.92B | -2.80B | -2.75B | -3.03B |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -95.00M | -205.00M | -211.00M | -9.54B | -16.61B |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -4.74B | -5.18B | -2.72B | -2.17B | -1.25B |
Cash from Investing | -7.61B | -8.31B | -5.73B | -14.47B | -20.89B |
Total Debt Issued | 9.83B | 5.76B | 4.16B | 12.67B | 16.10B |
Total Debt Repaid | -4.77B | -2.14B | -1.62B | -7.82B | -8.17B |
Issuance of Common Stock | 361.00M | 377.00M | 385.00M | 384.00M | 277.00M |
Repurchase of Common Stock | -3.21B | -3.21B | -3.21B | -3.20B | -2.19B |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -3.37B | -3.31B | -3.26B | -3.19B | -3.13B |
Other Financing Activities | 26.00M | -13.00M | -110.00M | -106.00M | -201.00M |
Cash from Financing | -1.14B | -2.54B | -3.65B | -1.27B | 2.68B |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 359.00M | -6.24B | -1.31B | -4.85B | -4.78B |